Language
English
German
^M
Dutch
Spanish
Title:
Development trends for monoclonal antibody cancer therapeutics
Source:
Nature Reviews Drug Discovery [1474-1776] Reichert, Janice yr:2007
Basic
Full text
Full text available via
Nature
Year:
Volume:
Issue:
Start Page:
Document delivery
Request document via
Library/Bibliothek
Users interested in this article also expressed an interest in the following:
description
1.
Weiner, L.
"Monoclonal antibodies: versatile platforms for cancer immunotherapy."
Nature Reviews. Immunology
10.5 (2010): 317-327.
description
2.
Beck, A.
"Strategies and challenges for the next generation of therapeutic antibodies."
Nature Reviews. Immunology
10.5 (2010): 345-352.
description
3.
Faivre, S.
"Molecular basis for sunitinib efficacy and future clinical development."
Nature reviews. Drug discovery
6.9 (2007): 734-745.
description
4.
Berry, Jody D.
"Antibodies in infectious diseases: Polyclonals, monoclonals and niche biotechnology."
New biotechnology
28.5 (2011): 489-501.
description
5.
Steinitz, M.
"Three decades of human monoclonal antibodies: Past, present and future developments."
Human Antibodies
18.1/2 (2009): 1-10.
description
6.
Alley, Stephen C.
"Antibody–drug conjugates: targeted drug delivery for cancer."
Current opinion in chemical biology
14.4 (2010): 529-537.
description
7.
Adams, Gregory P P.
"Monoclonal antibody therapy of cancer."
Nature biotechnology
23.9 (2005): 1147-57.
description
8.
Weiner, L.
"Monoclonal antibodies for cancer immunotherapy."
The Lancet
373.9668 (2009): 1033-1040.
description
9.
Bradbury, Andrew R.
"Beyond natural antibodies: the power of in vitro display technologies."
Nature biotechnology
29.3 (2011): 245-254.
description
10.
Chan, Andrew C.
"Therapeutic antibodies for autoimmunity and inflammation."
Nature Reviews. Immunology
10.5 (2010): 301-316.
description
11.
Thmmes, A.
"Recent advances in large-scale production of monoclonal antibodies and related proteins."
Trends in biotechnology
28.5 (2010): 253-261.
description
12.
Laffly, E.
"Monoclonal and recombinant antibodies, 30 years after..."
Human Antibodies
14.1-2 (2005): 33-55.
description
13.
Saini, Kamal S.
"Beyond trastuzumab: New treatment options for HER2-positive breast cancer."
Breast
20.Supplement 3 (2011): 20-7.
description
14.
Moreno Aspitia, A.
"Neoadjuvant therapy in early-stage breast cancer."
Critical reviews in oncology/hematology
82.2 (2011): 187-199.
description
15.
Damle, N.
"Antibody-drug conjugates ace the tolerability test."
Nature Biotechnology
26.8 (2008): 884-885.
description
16.
Sandlie, I.
"Therapeutic antibodies for human diseases at the dawn of the twenty-first century."
Nature reviews. Drug discovery
2.1 (2002): 52-62.
description
17.
RS Chambers, R.
"High-throughput antibody production."
Current opinion in chemical biology
9.1 (2005): 46-50.
description
18.
Jack, George W.
"Immunoaffinity chromatography."
Methods in molecular biology
59.Protein Purification Protocols (1996): 187-60.
description
19.
Berry, Jody D.
"Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale."
The veterinary journal
170.2 (2005): 193-211.
description
20.
Cao, Yihai H.
"Antiangiogenic cancer therapy."
Seminars in cancer biology
14.2 (2004): 139-145.
View More...
View Less...
Select All
Clear All
Save Citations
Select Format
ProCite
EndNote
Reference Manager
RefWorks
Submit citation export
Advanced
Author
Other articles by this author? -- in
GeoRef
author:
Reichert, Janice M
Valge Archer, Viia E
last name
initials
Other articles by this author? -- in
Online Contents Geosciences
author:
Reichert, Janice M
Valge Archer, Viia E
last name
initials
Web Search
Find related information in
a Web Search Engine
Excite
Google
HotBot
Ixquick
ZOO
Ask
Yahoo!
Bing
Naver
Search Terms:
Search for related information in
Google Scholar
Article Title
Author Name
Journal Title
Other Search
Search Terms:
A service provided by the
Library of the Wissenschaftspark Albert Einstein
, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.